Myriad Genetics, Inc. Stock price
Equities
MYGN
US62855J1043
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.63 USD | +2.22% | -4.21% | +13.01% |
Feb. 27 | Transcript : Myriad Genetics, Inc., Q4 2023 Earnings Call, Feb 27, 2024 | |
Feb. 27 | Earnings Flash (MYGN) MYRIAD GENETICS Reports Q4 EPS $0.04, vs. Street Est of $0.01 | MT |
Financials (USD)
Sales 2024 * | 828M | Sales 2025 * | 898M | Capitalization | 1.94B |
---|---|---|---|---|---|
Net income 2024 * | -91M | Net income 2025 * | -63M | EV / Sales 2024 * | 2.32 x |
Net cash position 2024 * | 21.96M | Net Debt 2025 * | 10.91M | EV / Sales 2025 * | 2.18 x |
P/E ratio 2024 * |
-23.4
x | P/E ratio 2025 * |
-35.5
x | Employees | 2,700 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.33% |
Latest transcript on Myriad Genetics, Inc.
1 day | +2.22% | ||
1 week | -4.21% | ||
Current month | +3.34% | ||
1 month | -6.97% | ||
3 months | +5.77% | ||
6 months | +27.01% | ||
Current year | +13.01% |
Managers | Title | Age | Since |
---|---|---|---|
Paul Diaz
CEO | Chief Executive Officer | 61 | 20-08-12 |
Scott Leffler
DFI | Director of Finance/CFO | 49 | Jan. 28 |
Dale Muzzey
CTO | Chief Tech/Sci/R&D Officer | 44 | 14-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
S. Phanstiel
CHM | Chairman | 65 | 09-09-15 |
Paul Bisaro
BRD | Director/Board Member | 63 | 22-10-30 |
Dan Spiegelman
BRD | Director/Board Member | 65 | 20-05-26 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.24% | 17 M€ | -2.09% | ||
0.26% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-03-18 | 21.63 | +2.22% | 620,560 |
24-03-15 | 21.16 | -0.75% | 2,270,198 |
24-03-14 | 21.32 | -0.98% | 872,236 |
24-03-13 | 21.53 | -0.19% | 456,571 |
24-03-12 | 21.57 | -4.47% | 496,301 |
Delayed Quote Nasdaq, March 18, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.01% | 1.94B | |
-2.52% | 12.59B | |
+6.04% | 9.05B | |
+9.74% | 5.05B | |
-35.53% | 4.3B | |
-8.84% | 3.87B | |
+10.88% | 2.72B | |
-0.26% | 2.52B | |
+14.30% | 1.93B | |
+8.53% | 1.69B |